Oral GLP-1 Drugs Target Brain’s Food Reward | Science News

New oral GLP-1 drugs like orforglipron and danuglipron may be rewiring the brain’s reward system—not just curbing hunger but dialing down cravings for pleasurable food by targeting the central amygdala. This breakthrough could revolutionize treatment for overeating and even addiction, offering a deeper, more powerful approach than injectable versions ever did. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/7403a568d2b77609